Satellite Banner
Technology Networks Header
Thursday, October 23, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Bioo Scientific First to Address Small RNA-Seq Bias Concerns
Wednesday, August 13, 2014
Company launches NEXTflex™ Small RNA Sequencing Kit v2.

Cancer Conference Poster Prize Winner Announced
Monday, August 11, 2014
Katarzyna Grzes, winner of the AMSBIO-Trevigen prize for the best poster, is a PhD researcher specialising in Cell Signaling and Immunology.

Cancer Conference Poster Prize Winner
Friday, July 25, 2014
Katarzyna Grzes announced as the winner of the AMSBIO-Trevigen prize for the best poster.

EKF Diagnostics’ Growing Product Portfolio Highlighted at AACC 2014
Thursday, July 24, 2014
From early detection of ketosis to cancer mutation testing in whole blood.

Bioo Scientific Launches 16S V1 – V3 rRNA Library Prep Kits for Bacterial Metagenomics Studies
Wednesday, July 23, 2014
This kit allows users to go from sample to sequence in two hours, making it the fastest library prep kit available.

New Data Using EKF PointMan™ Technology
Tuesday, July 22, 2014
New data suggest the possibility of a simple blood test for cancers.

ChIP Sequencing Kit for Next Generation Sequencing
Tuesday, July 22, 2014
Company extends the benefits of their Chromatrap® solid state ChIP technology.

ACD’s RNAscope® In Situ Hybridization Technology Gains Significant Traction
Wednesday, July 16, 2014
Highly sensitive and easy-to-use technology validated in over 100 papers in three years.

QIAGEN Launch of 14 New Cancer Gene Panels
Wednesday, July 16, 2014
QIAGEN introduces 14 new panels for targeted enrichment of up to 570 clinically-relevant genes, expands largest portfolio of panels for assessing cancer genes.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 2528
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv